Research is critical when it comes to battling hard-to-treat childhood cancers. The Children’s Foundation has contributed two research grants: One to develop new treatments for acute myeloid leukemia (AML), when a child’s bone marrow makes abnormal cells; the other focusing on neuroblastoma, which starts in nerve cells and forms tumors in various parts of the body.
The Children’s Foundation has supported a number of grants focused on Pediatric Research. These grants support experiential and ground breaking technology that has helped find new ways to monitor infants with complex heart defects, improve outcomes for young catheterization patients and develop new procedures and treatment for pediatric heart surgery.
While there have been tremendous improvements in outcomes for many children with cancer, survival remains very poor for children with certain types of cancer, like brain cancer or recurrent cancers. And for minority children like Lakelyn was diagnosed with brain cancer at just three months old, the response to treatment is about 15% inferior compared to their counterparts. That is why Children’s Foundation is supporting a multi-institutional research project to advance and improve brain cancer treatment for all children. By focusing on the genetic landscape of minority children, researchers hope to improve response rates to cancer treatment.